Fifth Third Bancorp’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,627
| Closed | -$299K | – | 2801 |
|
|
2021
Q2 | $299K | Buy |
1,627
+151
| +10% | +$25.9K | ﹤0.01% | 855 |
|
|
2021
Q1 | $226K | Sell |
1,476
-102
| -6% | -$15.8K | ﹤0.01% | 909 |
|
|
2020
Q4 | $247K | Buy |
1,578
+353
| +29% | +$45.4K | ﹤0.01% | 857 |
|
|
2020
Q3 | $140K | Buy |
1,225
+469
| +62% | +$50.6K | ﹤0.01% | 1005 |
|
|
2020
Q2 | $85K | Sell |
756
-257
| -25% | -$27.3K | ﹤0.01% | 1146 |
|
|
2020
Q1 | $91K | Buy |
1,013
+145
| +17% | +$14.2K | ﹤0.01% | 1066 |
|
|
2019
Q4 | $94K | Buy |
868
+230
| +36% | +$24.6K | ﹤0.01% | 1190 |
|
|
2019
Q3 | $62K | Sell |
638
-375
| -37% | -$42.3K | ﹤0.01% | 1282 |
|
|
2019
Q2 | $133K | Sell |
1,013
-94
| -8% | -$12.1K | ﹤0.01% | 1038 |
|
|
2019
Q1 | $150K | Sell |
1,107
-665
| -38% | -$82.7K | ﹤0.01% | 945 |
|
|
2018
Q4 | $173K | Sell |
1,772
-226
| -11% | -$26.7K | ﹤0.01% | 894 |
|
|
2018
Q3 | $278K | Sell |
1,998
-11,096
| -85% | -$1.39M | ﹤0.01% | 803 |
|
|
2018
Q2 | $1.63M | Sell |
13,094
-24,248
| -65% | -$2.83M | 0.01% | 413 |
|
|
2018
Q1 | $4.16M | Sell |
37,342
-2,443
| -6% | -$292K | 0.03% | 295 |
|
|
2017
Q4 | $4.76M | Sell |
39,785
-23,541
| -37% | -$2.87M | 0.03% | 287 |
|
|
2017
Q3 | $8.88M | Sell |
63,326
-3,254
| -5% | -$442K | 0.06% | 226 |
|
|
2017
Q2 | $8.1M | Sell |
66,580
-1,913
| -3% | -$223K | 0.06% | 231 |
|
|
2017
Q1 | $8.3M | Sell |
68,493
-2,316
| -3% | -$299K | 0.06% | 227 |
|
|
2016
Q4 | $8.66M | Sell |
70,809
-14,929
| -17% | -$1.83M | 0.07% | 223 |
|
|
2016
Q3 | $10.5M | Buy |
85,738
+1,689
| +2% | +$217K | 0.09% | 199 |
|
|
2016
Q2 | $9.81M | Buy |
84,049
+1,745
| +2% | +$248K | 0.08% | 204 |
|
|
2016
Q1 | $11.5M | Sell |
82,304
-22,172
| -21% | -$3.26M | 0.1% | 194 |
|
|
2015
Q4 | $19.9M | Buy |
104,476
+4,806
| +5% | +$840K | 0.18% | 138 |
|
|
2015
Q3 | $15.6M | Buy |
99,670
+29,427
| +42% | +$5.37M | 0.14% | 158 |
|
|
2015
Q2 | $12.7M | Buy |
70,243
+69,172
| +6,459% | +$11.9M | 0.11% | 184 |
|
|
2015
Q1 | $186K | Buy |
1,071
+149
| +16% | +$27K | ﹤0.01% | 1013 |
|
|
2014
Q4 | $171K | Buy |
922
+50
| +6% | +$9.27K | ﹤0.01% | 995 |
|
|
2014
Q3 | $145K | Sell |
872
-232
| -21% | -$38.1K | ﹤0.01% | 1050 |
|
|
2014
Q2 | $173K | Sell |
1,104
-28
| -2% | -$4.42K | ﹤0.01% | 1001 |
|
|
2014
Q1 | $172K | Sell |
1,132
-1,992
| -64% | -$317K | ﹤0.01% | 973 |
|
|
2013
Q4 | $415K | Buy |
3,124
+2,501
| +401% | +$300K | ﹤0.01% | 760 |
|
|
2013
Q3 | $72K | Sell |
623
-7
| -1% | -$768 | ﹤0.01% | 1151 |
|
|
2013
Q2 | $58K | Buy |
+630
| New | +$60.7K | ﹤0.01% | 1247 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM